USE OF TYPE V PHOSPHODIESTERASE INHIBITORS IN THE TREATMENT OF EXERCISE INDUCED PULMONARY HEMORRHAGE IN THE EQUINE

摘要

The use of type V phosphodiesterase inhibitors as a novel independent therapeutic modality in the treatment of exercise induced pulmonary hemorrhage in equine is described. The type V phosphodiesterase inhibitor is injected into the horse intravenously as a stand-alone agent from about one-half hour to about seven (7) days prior to the onset of strenuous exercise.